Cargando…

TNF-Related Apoptosis Inducing Ligand in Ocular Cancers and Ocular Diabetic Complications

TNF-related apoptosis inducing ligand (TRAIL) is an intensively studied cytokine, in particular for its anticancer activity. The discovery that conjunctival sac fluid contains extremely high levels of soluble TRAIL as compared to other body fluids suggested important implications in the context of t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Perri, Paolo, Zauli, Giorgio, Gonelli, Arianna, Milani, Daniela, Celeghini, Claudio, Lamberti, Giuseppe, Secchiero, Paola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4365302/ https://www.ncbi.nlm.nih.gov/pubmed/25834817 http://dx.doi.org/10.1155/2015/424019

Ejemplares similares

Association of Serum Tumor Necrosis Factor-Related Apoptosis Inducing Ligand with Body Fat Distribution as Assessed by Dual X-Rays Absorptiometry
por: Cervellati, Carlo, et al.
Publicado: (2014)

Levels of circulating TNF-related apoptosis-inducing ligand in celiac disease
por: CELEGHINI, CLAUDIO, et al.
Publicado: (2014)

Upregulation of SOCS-1 by Nutlin-3 in acute myeloid leukemia cells but not in primary normal cells
por: Tisato, Veronica, et al.
Publicado: (2014)

Treatment With Recombinant Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Alleviates the Severity of Streptozotocin-Induced Diabetes
por: Zauli, Giorgio, et al.
Publicado: (2010)

Kinetic Profiles of Inflammatory Mediators in the Conjunctival Sac Fluid of Patients upon Photorefractive Keratectomy
por: Tisato, Veronica, et al.
Publicado: (2015)

Sex/Gender-Specific Imbalance in CVD: Could Physical Activity Help to Improve Clinical Outcome Targeting CVD Molecular Mechanisms in Women?
por: Vaccarezza, Mauro, et al.
Publicado: (2020)

Clinical perspectives of TRAIL: insights into central nervous system disorders
por: Tisato, Veronica, et al.
Publicado: (2016)

MDM2/X inhibitors under clinical evaluation: perspectives for the management of hematological malignancies and pediatric cancer
por: Tisato, Veronica, et al.
Publicado: (2017)

Activation of PKC-ε counteracts maturation and apoptosis of HL-60 myeloid leukemic cells in response to TNF family members
por: Gonelli, A., et al.
Publicado: (2009)

Overcoming of Microenvironment Protection on Primary Chronic Lymphocytic Leukemia Cells after Treatment with BTK and MDM2 Pharmacological Inhibitors
por: Rimondi, Erika, et al.
Publicado: (2021)

TRAIL, OPG, and TWEAK in kidney disease: biomarkers or therapeutic targets?
por: Bernardi, Stella, et al.
Publicado: (2019)

Cell-Based Therapies for Diabetic Complications
por: Bernardi, Stella, et al.
Publicado: (2012)

Association of Soluble Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) with Central Adiposity and Low-Density Lipoprotein Cholesterol
por: Brombo, Gloria, et al.
Publicado: (2013)

p53/NF-kB Balance in SARS-CoV-2 Infection: From OMICs, Genomics and Pharmacogenomics Insights to Tailored Therapeutic Perspectives (COVIDomics)
por: Milani, Daniela, et al.
Publicado: (2022)

State of the Art of Pharmacological Activators of p53 in Ocular Malignancies
por: Casciano, Fabio, et al.
Publicado: (2023)

Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3
por: Agnoletto, Chiara, et al.
Publicado: (2014)

Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia
por: Voltan, Rebecca, et al.
Publicado: (2016)

Soluble TRAIL does not impair the anti-osteoclastic activity of osteoprotegerin
por: Zauli, Giorgio, et al.
Publicado: (2008)

Rationale for Considering Oral Idasanutlin as a Therapeutic Option for COVID-19 Patients
por: Zauli, Giorgio, et al.
Publicado: (2020)

Mitochondria-Targeted Antioxidants, an Innovative Class of Antioxidant Compounds for Neurodegenerative Diseases: Perspectives and Limitations
por: Fields, Matteo, et al.
Publicado: (2023)

TRAIL and Ceruloplasmin Inverse Correlation as a Representative Crosstalk between Inflammation and Oxidative Stress
por: Tisato, Veronica, et al.
Publicado: (2018)

Ocular Complications in Smallpox
por: Sen, K.
Publicado: (1945)

Ocular Complications of Diabetes and Therapeutic Approaches
por: Vieira-Potter, Victoria J., et al.
Publicado: (2016)

Ocular Complications of Diabetes and Therapeutic Approaches
por: Romero-Aroca, Pedro
Publicado: (2022)

TRAIL Modulates the Immune System and Protects against the Development of Diabetes
por: Bossi, Fleur, et al.
Publicado: (2015)

Ocular complications of bungee jumping
por: Hassan, H Mohammed J, et al.
Publicado: (2012)

The Ocular Complications of Epidemic Dropsy
por: Kirwan, E. O'G.
Publicado: (1935)

Ocular complications of antineoplastic therapies
por: Bader, Abbas, et al.
Publicado: (2023)

Therapy of ocular complications in ANCA+ associated vasculitis
por: Macarie, Sorin Simion, et al.
Publicado: (2021)

Editorial: Ocular complications associated with diabetes mellitus
por: Zhang, Xinyuan, et al.
Publicado: (2023)

Lipids at the Nexus between Cerebrovascular Disease and Vascular Dementia: The Impact of HDL-Cholesterol and Ceramides
por: Sergi, Domenico, et al.
Publicado: (2023)

Autoinflammatory Diseases and Cytokine Storms—Imbalances of Innate and Adaptative Immunity
por: Marcuzzi, Annalisa, et al.
Publicado: (2021)

Effects of Hypoxia and Bed Rest on Markers of Cardiometabolic Risk: Compensatory Changes in Circulating TRAIL and Glutathione Redox Capacity
por: Biolo, Gianni, et al.
Publicado: (2018)

An anti-TNF-α antibody mimetic to treat ocular inflammation
por: Khalili, Hanieh, et al.
Publicado: (2016)

Ocular Complications After Radiation Therapy: An Observational Study
por: Nuzzi, Raffaele, et al.
Publicado: (2020)

Ocular Toxocariasis
por: Pivetti-Pezzi, Paola
Publicado: (2009)

Ocular Complications of Inflammatory Bowel Disease
por: Mady, Rana, et al.
Publicado: (2015)

Ocular complications of spitting cobra venom
por: Jalink, Maarten B
Publicado: (2020)

Ocular Complications of Obstructive Sleep Apnea
por: Liu, Pei-Kang, et al.
Publicado: (2021)

Homocystinuria and ocular complications – A review
por: Rahman, Mehzabeen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4qth41dh1r7vkpanvl7mj246qt